Clinical trial NCT02041910: Testicular Injection of Autologous Stem Cells for Treatment of Patients With Azoospermia
Official title: Testicular Injection of Autologous Human Bone Marrow Derived Stem Cells for Treatment of Patients With Azoospermia
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: PHASE1
PHASE2
Conditions: Azoospermia
Lead sponsor: El-Rayadh Fertility Centre
Sponsor class: OTHER
First posted: 2014-01-22
Enrollment: 60
Sex: MALE
Minimum age (years): 25
Maximum age (years): 60
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: SINGLE_GROUP
Primary purpose: TREATMENT

Brief summary: Azoospermia is defined as the complete lack of sperm in the ejaculate. In humans, Azoospermia affects about 1% of the male population and may be seen in up to 20% of male infertility situations. In testicular Azoospermia the testes are abnormal, atrophic, or absent, and sperm production severely disturbed to absent. FSH levels tend to be elevated (hypergonadotropic) as the feedback loop is interrupted. The condition is seen in 49-93% of men with Azoospermia. The purpose of this study is to assess the ability of bone marrow derived stem cells to differentiate into germ cells and their role in treatment of testicular Azoospermia

Detailed description: This study is an open-label investigation of the efficacy of injection autologous adult bone marrow derived stem cells into the somniferous tubules or interstitial spaces of male testis with Azospermia. Sixty men with Azoospermia will be recruited in this study after a written informed consent.

The diagnosis of Azoospermia will be established on the basis of two semen analysis evaluations done at separate occasions; this will be followed by detailed history taking, physical examination and investigations. History taking will include general health, sexual health, past fertility, libido, sexual activity and previous exposure to surgery, drugs, mumps infection and irradiation. Physical examination includes genital and local examination for detection of signs of Klinefelter syndrome, testicular atrophy, absence of vas. Investigations include serum FSH, LH, karyotyping and testosterone levels, and may include testicular biopsy or transrectal ultrasound if indicated (Low levels of LH and FSH with low or normal testosterone levels are indicative of pretesticular problems, while high levels of gonadotropins indicate testicular problems. However, often this distinction is not clear and the differentiation between obstructive versus non-obstructive Azoospermia may require a testicular biopsy).

Subjects will be enrolled based on specific inclusion/exclusion criteria and evaluated at regular post transplant intervals. Human adult bone marrow derived stem cells will be transplanted by an andrological surgeon through a standard surgical approach. Subjects will be monitored frequently for a total of one year after adult bone marrow stem cells cell injection. For safety of participants, Bone Marrow Stem cells will be injected in one testis only and the other testis will be spared.

Eligibility criteria: Inclusion Criteria:

* Patients with non-obstructive Azoospermia
* Patients between 25 - 60 years old.

Exclusion Criteria:

* Patients with obstructive Azoospermia
* Men with previous surgery in testis
* Men with infectious genital diseases and anatomical abnormalities of the genital tract
* Those with major medical problems such as malignancy, hepatitis, etc.
* Chromosomal aberration (e.g. Y microdeleion, trisomy....)

Primary outcomes:
measure: Cases Improvement
timeFrame: 12 Weeks
Secondary outcomes:
measure: Cases Improvement
timeFrame: 48 Weeks
Other outcomes:
Locations:
city: Al Mohandseen
country: Egypt
facility: El-Rayadh Fertility Center
state: Giza
Study officials:
affiliation: Al-Azhar University
name: Taimour Khalifa, MD
role: PRINCIPAL_INVESTIGATOR
affiliation: Al-Azhar University
name: Sayed Bakry, PhD
role: STUDY_DIRECTOR
affiliation: Cairo University
name: Hala Gabr, MD
role: STUDY_CHAIR
affiliation: Military Academy
name: Wael Abu El Khier, MD
role: STUDY_CHAIR
References: